Search
- Page Path
- HOME > Search
Original Article
- Prevalence of Dyslipidemia and Hypertension in Indian Type 2 Diabetic Patients with Metabolic Syndrome and its Clinical Significance
- Dhananjay Yadav, Meerambika Mishra, Arvind Tiwari, Prakash Singh Bisen, Hari Mohan Goswamy, G.B.K.S. Prasad
- Osong Public Health Res Perspect. 2014;5(3):169-175. Published online June 30, 2014
- DOI: https://doi.org/10.1016/j.phrp.2014.04.009
- 3,625 View
- 30 Download
- 19 Crossref
-
Abstract
PDF - Objectives
The present study was designed to estimate the prevalence of dyslipidemia and hypertension based on the National Cholesterol Educational Programme Adult Treatment Panel III definition of metabolic syndrome (MetS). The study also focuses on prevalence for MetS with respect to the duration of disease in Gwalior–Chambal region of Madhya Pradesh, India.
Methods
Type 2 diabetic patients (n = 700) were selected from a cross-sectional study that is regularly being conducted in the School of Studies in Biochemistry, Jiwaji University Gwalior, India. The period of our study was from January 2007 to October 2009. Dyslipidemia and hypertension were determined in type 2 diabetic patients with MetS as per National Cholesterol Educational Programme Adult Treatment Panel III criteria.
Results
The mean age of the study population was 54 ± 9.3 years with 504 (72%) males and 196 (28%) females. The prevalence of MetS increased with increased duration of diabetes in females; however, almost constant prevalence was seen in the males. Notable increase in the dyslipidemia (64.1%) and hypertension (49%) in type 2 diabetic patients were seen. The steep increase in dyslipidemia and hypertension could be the reason for the growing prevalence of diabetes worldwide. The study also noted a close association between age and occurrence of MetS.
Conclusion
Individual variable of MetS appears to be highly rampant in diabetic population. Despite treatment, almost half of patients still met the criteria for MetS. Effective treatment of MetS components is required to reduce cardiovascular risk in diabetes mellitus hence accurate and early diagnosis to induce effective treatment of MetS in Indian population will be pivotal in the prevention of cardiovascular disease and type 2 diabetes. -
Citations
Citations to this article as recorded by
- Complete blood count inflammation derived indexes as predictors of metabolic syndrome in type 2 diabetes mellitus
Almir Fajkić, Rijad Jahić, Edin Begić, Amela Dervišević, Avdo Kurtović, Orhan Lepara
Technology and Health Care.2024; 32(4): 2321. CrossRef - Mapping multimorbidity from diabetes mellitus and its association with depressive symptoms among older people of India: a cross-sectional study from a nationally representative survey
Gayatri Khanal, Y. Selvamani, J. Kezia Angeline
International Journal of Diabetes in Developing Co.2024;[Epub] CrossRef - Metabolic Syndrome Frequency in Type 2 Diabetics Using International Diabetes Federation (IDF) Criteria Analysis
Sheena Kumari, Disha K Kataria, Sona Kumari, Riya Rani, Neha Ahuja, FNU Partab, Sooraj Raja, Hafsa Asif, FNU Sanam, Mohsin Ali
Cureus.2024;[Epub] CrossRef - Prevalence of metabolic syndrome and its risk factors among newly diagnosed type 2 diabetes mellitus patients – A hospital-based cross-sectional study
S Teja Rama Krishna, Yogesh Bahurupi, Ravi Kant, Pradeep Aggarwal, Athulya V. Ajith
Journal of Family Medicine and Primary Care.2024; 13(8): 3325. CrossRef - Metabolic and genetic risk factors associated with pre-diabetes and type 2 diabetes in Thai healthcare employees: A long-term study from the Siriraj Health (SIH) cohort study
Pichanun Mongkolsucharitkul, Apinya Surawit, Thamonwan Manosan, Suphawan Ophakas, Sophida Suta, Bonggochpass Pinsawas, Tanyaporn Pongkunakorn, Sureeporn Pumeiam, Winai Ratanasuwan, Mayuree Homsanit, Keerati Charoencholvanich, Yuthana Udomphorn, Bhoom Sukt
PLOS ONE.2024; 19(6): e0303085. CrossRef - Utilization of Hypolipidemic Drugs, Patterns, and Factors Affecting Dyslipidemia Among Type 2 Diabetes Mellitus at a Tertiary Care Teaching Hospital in South India
Sandeep Khot, Ananya Chakraborty, Savitha Vijaykumar
Cureus.2023;[Epub] CrossRef - Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus
P Panneerselvam, Dibakar Biswas, Hema Singh, K Dilip Kumar, P Ravi Kumar, Pramila Kalra, Santosh Revankar, Sona Warrier
Cureus.2023;[Epub] CrossRef - Magnitude and Determinants of Diabetic Retinopathy Among Indian Diabetic Patients Undergoing Telescreening in India
Rajiv Khandekar, Tamilarasan Senthil, Malathi Nainappan, Deepak P. Edward
Telemedicine and e-Health.2022; 28(2): 176. CrossRef - An experimental study of rosuvastatin’s analgesic effect and its interaction with etoricoxib, tramadol, amlodipine, and amitriptytline in albino mice
Prafull Mohan, Ashok Kumar Sharma, Sharmila Sinha, R. Sabarad
Medical Journal Armed Forces India.2022; 78: S61. CrossRef - Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke
Nivedita L. Rao, Greeshma B. Kotian, Jeevan K. Shetty, Bhaskara P. Shelley, Mackwin Kenwood Dmello, Eric C. Lobo, Suchetha Padar Shankar, Shellette D. Almeida, Saiqa R. Shah
Biomolecules.2022; 12(11): 1712. CrossRef - Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
Sanjay Kalra, Ambika Gopalakrishnan Unnikrishnan, Manash P Baruah, Rakesh Sahay, Ganapathi Bantwal
Diabetes, Metabolic Syndrome and Obesity: Targets .2021; Volume 14: 165. CrossRef - Association between diet quality scores, adiposity, glycemic status and nutritional biomarkers among Indian population with type 2 diabetes mellitus: A cross-sectional study
Aamir Bashir, Krishna Pandey, Md Azharuddin, Anjali Kumari, Ishfaq Rashid, N.A. Siddiqui, Chandra Shekhar Lal, Krishna Murti
Clinical Epidemiology and Global Health.2020; 8(1): 53. CrossRef The Impact of BMI Categories on Metabolic Abnormality Development in Chinese Adults Who are Metabolically Healthy: A 7-Year Prospective Study
Xiangtong Liu, Jingbo Zhang, Jingwei Wu, Xiaolin Xu, Lixin Tao, Yue Sun, Shuo Chen, Yumei Han, Yanxia Luo, Xinghua Yang, Xiuhua Guo
Diabetes, Metabolic Syndrome and Obesity: Targets .2020; Volume 13: 819. CrossRef- Metabolic syndrome in north Indian type 2 diabetes mellitus patients: A comparison of four different diagnostic criteria of metabolic syndrome
Deepak Gahlan, Rajesh Rajput, Vandana Singh
Diabetes & Metabolic Syndrome: Clinical Research &.2019; 13(1): 356. CrossRef - Prevalence of Type 2 Diabetes and Prediabetes in the Gwalior-Chambal Region of Central India
Senthil Kumar Subramani, Dhananjay Yadav, Meerambika Mishra, Umamaheswari Pakkirisamy, Prakesh Mathiyalagen, GBKS Prasad
International Journal of Environmental Research an.2019; 16(23): 4708. CrossRef - A PROSPECTIVE STUDY OF DYSLIPIDAEMIA AND OBESITY IN HYPERTENSION PATIENTS
Ponnana Raja Kumar, Siripurapu Sasikala
Journal of Evidence Based Medicine and Healthcare.2018; 5(1): 43. CrossRef - Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India)
Sandipana Pati, F. G. Schellevis, Alessandra Marengoni
PLOS ONE.2017; 12(8): e0181661. CrossRef - Dyslipidemia Prevalence in Iranian Adult Men: The Impact of Population-Based Screening on the Detection of Undiagnosed Patients
Abolfazl Mohammadbeigi, Esamil Moshiri, Narges Mohammadsalehi, Hossein Ansari, Ali Ahmadi
The World Journal of Men's Health.2015; 33(3): 167. CrossRef - Association of high-density lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults
Xiangtong Liu, Lixin Tao, Kai Cao, Zhaoping Wang, Dongning Chen, Jin Guo, Huiping Zhu, Xinghua Yang, Youxin Wang, Jingjing Wang, Chao Wang, Long Liu, Xiuhua Guo
BMC Public Health.2015;[Epub] CrossRef
- Complete blood count inflammation derived indexes as predictors of metabolic syndrome in type 2 diabetes mellitus
First
Prev
